Orthopedic surgeons know the drill: you’re handed a 2D image, expected to build a 3D mental map, and then trusted to land a needle or probe precisely where it needs to go — all while glancing between a patient and a monitor halfway across the room. It’s impressive, but it’s also outdated.
Cleveland, Ohio-based MediView XR, Inc. thinks it’s time for a change, and thanks to a fresh $24 million Series A round, the company is gearing up to transform how interventional procedures are visualized and executed.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.

